NCT05162508View on ClinicalTrials.gov

Impact of COVID-19 SARS-CoV-2 Variability in ICU Hospitalized Patients With Severe Disease

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

December 16, 2021

Primary Completion Date

January 16, 2026

Study Completion Date

January 16, 2026

Conditions
SARS-CoV2 InfectionCOVID-19 Acute Respiratory Distress SyndromeMutation
Interventions
OTHER

Nasopharyngeal swab

Nasopharyngeal swab available in Standard Of Care (SOC) will be analysed (Full-length SARS-CoV-2 RNA sequencing and Transcriptomic analyses)

Trial Locations (1)

94010

RECRUITING

Assistance Publique Hôpitaux de Paris - CHU HENRI MONDOR, Créteil

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER